hypogonadism; fda; endocrine society; health

Much more to the story here! * Longer-term studies are still needed to determine whether testosterone therapy is safe with respect to cardiovascular, thromboembolic, and prostatic diseases. However, recent placebo-controlled trials (of 1-4 years) of TRT offer reassurance about the risk of...